Klingman & Associates »

Phathom Pharmaceuticals shares owned by Klingman & Associates

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Klingman & Associates from 13F filings

Historical chart of Klingman & Associates investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Klingman & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Klingman & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $110k 10k 10.62

More positions owned by Klingman & Associates

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Min Vol (USMV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr Ibonds Dec 29 (IBDU)
Ishares Tr Ibds Dec28 Etf (IBDT)

View all positions for Klingman & Associates

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Carlyle
BlackRock
Ensign Peak Advisors
Vanguard Group
NEA Management Company
Avidity Partners Management
683 Capital Management
Jennison Associates
Gilder, Gagnon, Howe & Co
Propel Bio Management
Decheng Capital
Geode Capital Management
Kennedy Capital Management

View all funds holding Phathom Pharmaceuticals